|
Texas Medicaid/CHIP Vendor Drug Program
News Updates |
The Texas Health and Human Services subscription e-mail service makes it easier for the public to keep up-to-date on the latest news and information about health and human services, including the Medicaid/CHIP Vendor Drug Program. Users can select items of interest from a menu of categories covering all five Texas Health and Human Services agencies.
Those who opt to receive Vendor Drug notices will receive an email message when information is published that impacts pharmacy providers, including: new pharmacy initiatives, issues that affect payment, special bulletins, updates to the Medicaid Preferred Drug List (PDL), publication of the Rx Update newsletter, and improvements to the Vendor Drug Program website. |
|
News items:
-
August 23, 2010:
New Pharmacy Claims System Postponed
-
August 6, 2010:
New Pharmacy Claims System Postponed
- July 28, 2010: PCRA: Provider Training Webinar
- July 28, 2010: PCRA: Submitting Test Claims
- July 15, 2010:
Revised Payer Sheets now Available
-
July 14, 2010:
Vendor Drug Extends Life of Prescription
-
July 5, 2010: Vendor Drug Program Pharmacy Education Reminders:
72-Hour Emergency Supplies for Prior Authorization-Required Drugs
Separate Billing for Outpatient Prescriptions and DME
Temporary Medicaid Eligibility Verification Form (1027-A)
Submitting an Eligibility Verification (E1) Transaction
Comprehensive Care Program Assists Medicaid Children
Online Continuing Medicaid Education Courses
Medicaid/CHIP to IMPROVE State, Provider Communication
-
July 5, 2010: July Rx Update newsletter
- July 5, 2010: New Vendor Drug Claims Processing System Information
|
|
December 9, 2009: Tamiflu Suspension
The compounding procedure for Tamiflu suspension is provided for emergency use only when the suspension is not commercially available. Medicaid requires that providers dispense the quantity prescribed or ordered by the prescriber except as limited by the policies and procedures described in the Commission's Pharmacy Provider Handbook.
Furthermore, providers must bill for the amount actually dispensed and the quantities actually used in the compound. Claims can only be submitted for the actual amount prescribed. Claims must reflect the actual number of capsules used to make the compound. You cannot bill for 10 capsules if 4, 6, or 8 capsules were used to dispense the prescribed quantity of Tamiflu suspension.
|
|
October 6, 2009: CHIP Tamiflu Claims Rejecting for
“Drug Not Covered”
Tamiflu is covered by the
Children’s Health Insurance Program (CHIP). However, the Texas
Medicaid/CHIP Pharmacy Resolution Help Desk has received a number of
calls about CHIP claims for Tamiflu suspensions rejecting for error
code 7Ø (“Drug Not Covered”).
The “Drug Not Covered” rejection applies to the suspending vehicle
(i.e. Ora Plus, Ora Sweet, etc.) that stores are mixing with Tamiflu.
This rejection can be overridden at the store level by entering an
“8” in the “Submission Clarification Code” field (420-DK).
Providers should contact their software provider for assistance in
submitting this field or refer to the
Vendor Drug Pharmacy Procedure Manual.
In addition, the Texas Department of State Health Services has put
together seasonal flu information for individuals, families and
health care professionals at
TexasFlu.org.
|
|
September 25, 2009: Average Wholesale Price Reduction
On Saturday, September 26, 2009, First DataBank (FDB), a major pharmaceutical pricing service, plans to reduce the Average Wholesale Price (AWP) by approximately 4 percent for approximately 1,400 drug products identified in New England Carpenters Health Benefits Fund, et al, v. First DataBank, Inc.and McKesson Corporation. The Vendor Drug Program performs its own drug pricing and is not dependent on private pricing services, such as FDB. We receive pricing information directly from drug manufacturers. We will not make immediate, automatic changes to the AWP in Texas. As manufacturers send us new pricing information, it will be updated in our system, including any changes to the AWP.
|
|
October 20, 2009: Pharmacist
Administration of Immunizations
Effective October
1, 2009, pharmacies and pharmacists can enroll to administer
immunizations to Texas Medicaid clients. Pharmacies will be
reimbursed for the vaccines and their administration through the
Texas Medicaid & Healthcare Partnership (TMHP). Pharmacies must be
enrolled with TMHP to bill for the administration of the vaccines.
To enroll, a
pharmacist must obtain and provide proof of Texas Board of Pharmacy
licensure and certification to administer vaccinations. A criminal
background check will be performed on all pharmacists who submit an
application. All providers who enroll must first be enrolled as a
Medicare provider.
Pharmacies may
complete an online enrollment application via the TMHP
website. TMHP will have a shortened enrollment application for
pharmacies currently enrolled as durable medical equipment
providers. Those using the shortened application form will need to
submit a full application within six months. A completed
application must be submitted to TMHP before the end of the
six-month period to continue to be reimbursed by Texas Medicaid.
The shortened form is also available online.
The H1N1 vaccine
will be covered by Medicaid through TMHP. TMHP will only pay the
administration fee. The federal government will provide the H1N1
flu vaccine to pharmacies free of charge. Pharmacies will need a
medical director to receive the vaccine, and the medical director
will have to place orders. The antivirals Tamiflu and Relenza are
covered Vendor Drug items. They will not need prior authorization
approval and will not count in the three prescriptions per month
limit. For information about influenza, please visit the
texasflu.org.
Pharmacists are
reminded to enter all immunization information into the
ImmTrac system, the Texas immunization registry developed by the
Texas Department of State Health Services. |
|
|
|
May 3, 2010:
Certain Pancreatic Enzyme Drugs Removed from the Vendor Drug
Formulary
The Centers
for Medicare & Medicaid Services (CMS) has notified the Texas
Medicaid Vendor Drug Program in a letter dated April 29, 2010,
that Vendor Drug must remove certain pancreatic enzyme drugs
from its
formulary. The Food and Drug Administration (FDA) has
determined the following Exocrine Pancreatic Insufficiency drugs
are unapproved new drugs, and cannot be marketed without
appropriate FDA approval. Because these drugs do not have an
approved FDA application, CMS has determined that the following
drugs do not meet the definition of a covered outpatient drug,
and must be removed from the Vendor Drug Formulary. Please
refer to this attachment
for drugs that are no longer available for reimbursement through
Vendor Drug effective April 30, 2010, and for drugs that are
still available through the Vendor Drug (including the new
formulation of Creon).
May 5, 2010: Pharmacy Resolution Help Desk Technical Problems
The Medicaid/CHIP Vendor Drug Pharmacy Resolution Help Desk is continuing to experience system issues that began early Monday, May 3. As a result of these issues, calls from pharmacy providers are taking much longer to complete, and callers may get a busy signal. HHSC is working to resolve the issue as quickly as possible. In the meantime, here are some reminders about inquiries that pharmacies can complete without having to call the Help Desk.
Eligibility Verification: Vendor Drug encourages pharmacy providers to use their point-of-sale system to submit an Eligibility Verification (E1) Transaction to check eligibility status. If you do not know an individual’s Cardholder ID, you can submit the individual’s Social Security number, preceded by an ‘S’ (e.g., S123456798), to receive the client’s Cardholder ID on the returned response. Payer sheets for the E1 transaction are available in the Vendor Drug Procedure Manual.
National Drug Code (NDC) Inquiry: If you have a denied claim with the message “NDC Not Covered” and you need to determine what NDCs are covered, please refer to the online Vendor Drug formulary. The online product details will provide an effective date and end date (if applicable) for each program (Medicaid, CHIP, CSHCN, or KHC).
Prior Authorization (PA) Inquiry: If you are submitting a claim that requires a PA, the Prescriber will need to request the PA from the PA Texas Call Center at 1-877-PA-TEXAS (1-877-728-3927). Vendor Drug staff cannot remove the requirement for a PA.
We appreciate your patience and understanding as we continue working to resolve our technical difficulties and return to providing you timely service.
July 14, 2010: Vendor Drug Extends Life of Prescription
Earlier this year, the Centers for Medicare & Medicaid Services (CMS) approved the state’s amendment to increase the dispensing life of a Medicaid prescription from six months to one year for non-controlled substances and allow a maximum of up to 11 refills within a one-year period. The Vendor Drug Program will implement these changes on claims beginning Thursday, July 15, 2010.
August 6:
New Pharmacy Claims System Postponed
The
migration of the Texas Vendor Drug Program’s pharmacy
claims processing system has been postponed. The
migration was scheduled to occur on Monday, August 23,
2010, but will be rescheduled for a new date later this
year. Progress has been made toward completion of the
new system. Many pharmacies have successfully submitted
test claims. However, HHSC will take additional time to
thoroughly test all aspects of the new system to ensure
there is no interruption of service or payment. HHSC
will notify pharmacies and schedule additional pharmacy
training sessions when a new implementation date is
set. Until further notice, all scheduled educational
webinars are canceled and pharmacy providers should
continue to submit their prescription claims as they do
today.
August 23: Reminder: New Pharmacy Claims System Postponed
The migration to the new pharmacy claims processing system was scheduled to occur today, but has been rescheduled for later this year. This means all changes and new functionalities mentioned on our website and in our correspondence are delayed, including using the new Bank Information Number (BIN) and the new Processor Control Numbers (PCN), submitting the Prescriber National Provider Identifier (NPI), and any changes involving pharmacy payment and remittance advices. Please continue to submit all pharmacy B1, B2, and E1 transactions as you have done previously using the following information, where applicable:
- For all transactions, submit “Ø12338” in the “Bank Information Number” (BIN) field (1Ø1-A1).
- For all Medicaid, CHIP, and CSHCN claims, submit “PØ28Ø12338” in the “Processor Control Number” (PCN) field (1Ø4-A4).
- For all KHC claims, submit “PØ26Ø12338” in the PCN field.
- For all transactions, submit the 5-character State License Number in the “Prescriber ID” field (411-DB).
- Ensure you are also submitting “Ø8” in the “Provider ID Qualifier” field (466-EZ).
|
|
|
|
| |
|